Tesamorelin
$129.00
Skip to product information
Tesamorelin
$129.00
Tesamorelin
Potent GHRH analog and the only peptide in this class FDA-approved for reducing visceral adiposity in patients with HIV-associated lipodystrophy. It promotes GH and IGF-1 release, leading to reduced abdominal fat and improved body composition, while preserving lean muscle mass.
Stimulates GH secretion through pituitary GHRH receptors Increases IGF-1 levels to enhance lipolysis and tissue repair Reduces visceral fat while maintaining lean mass.
Stronger and longer-acting than CJC-1295. May cause significant IGF-1 elevation—monitor levels periodically.
All Boost Lab Australia products undergo independent third-party testing to verify purity, identity, and research reliability prior to sale. For research purposes only.